Chemical Biology & Drug Design · 2014 · 25 citations · 35 references
MedicineOncologyPharmacologyApoptosisChemotherapyPlant BiochemistryApoptosis PharmacologyCell Cycle PharmacologyMedicinal PlantsAurora Kinase FunctionAurora Kinase InhibitionBinding Mode AnalysisCaspase-mediated ApoptosisCell-based AssaysFlavonoid-mediated InhibitionKinase InhibitorsWestern Blot Analysis
Although several plant-derived flavones inhibit aurora B kinase (aurB), quantitative relationships between the structural properties of plant-derived flavones and their inhibitory effects on aurB remain unclear. In this report, these quantitative structure-activity relationships were obtained. For quercetagetin, found in the Eriocaulon species, showing the best IC50 value among the flavone derivatives tested in this report, further biological tests were performed using cell-based assays, including Western blot analysis, flow cytometry, and immunofluorescence microscopy. In vitro cellular experiments demonstrated that quercetagetin inhibits aurB. The molecular-binding mode between quercetagetin and aurB was elucidated using in silico docking. Quercetagetin binds to aurB, aurA, and aurC and prevents the active phosphorylation of all three aurora kinases. In addition, quercetagetin triggers mitotic arrest and caspase-mediated apoptosis. These observations suggest that quercetagetin is an aurora kinase inhibitor. Induction of mitosis-associated tumor cell death by quercetagetin is a promising strategy for developing novel chemotherapeutic anticancer agents.
35
Gerrit Koopman, CP Reutelingsperger, GA Kuijten et al. · Blood · 1994 · 2.5K citations · Full text
Medicine, Cell Biology, Pathology +11
Gerrit Koopman, CP Reutelingsperger, GA Kuijten et al. · Blood · 1994 · 2.1K citations
Medicine, Cell Biology, Pathology +11